|
C. Randal Mills Ph.D. President and Chief Executive Officer joined Osiris in July 2004. Dr. Mills is also a member of the Board of Directors. Prior to joining Osiris Dr. Mills was an executive officer of Regeneration Technologies Inc. (NASDAQ RTIX). Dr. Mills served in several leadership positions at RTI from its formation in 1998 until 2004 including Vice President of Business Development and Vice President of Operations and R&D and is credited with several key initiatives including the development and commercialization of RTI’s core technology BioCleanse®. Prior to RTI Dr. Mills was a member of the founding management team of the University of Florida Tissue Bank Inc. The University of Florida Tissue Bank was the predecessor company to RTI. Dr. Mills received a Bachelors degree in microbiology and cell science and a Ph.D. in drug development both from the University of Florida. | 